The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical Trials in Head Injury
Open accessAbstract
Traumatic brain injury (TBI) remains a major public health problem globally. In the United States the incidence of closed head injuries admitted to hospitals is conservatively estimated to be 200 per 100,000 population, and the incidence of penetrating head injury is estimated to be 12 per 100,000, the highest of any developed country in the world. This yields an approximate number of 500,000 new cases each year, a sizeable proportion of which demonstrate significant long-term disabilities. Unfortunately, there is a paucity of proven therapies for this disease. For a variety of reasons, clinical trials for this condition have been difficult to design and perform. Despite promising pre-clinical data, most of the trials that have been performed in recent years have failed to demonstrate any significant improvement in outcomes. The reasons for these failures have not always been apparent and any insights gained were not always shared. It was therefore feared that we were running the risk of repeating our mistakes. Recognizing the importance of TBI, the National Institute of Neurological Disorders and Stroke (NINDS) sponsored a workshop that brought together experts from clinical, research, and pharmaceutical backgrounds. This workshop proved to be very informative and yielded many insights into previous and future TBI trials. This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite preclinical studies providing evidence for successful pharmacologic intervention, more than 30 phase-III clinical trials have failed to improve secondary injury outcome measures after TBI (35–37).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research works printed but not linked: 42
- 10.1136/bmj.314.7098.1855 · DOI
- 10.1080/01616412.1995.11740326 · DOI
- 10.3171/jns.1983.58.3.0326 · DOI
- 10.1089/neu.1998.15.771 · DOI
- 10.1179/016164101101198325 · DOI
- 10.1097/00006123-199307000-00005 · DOI
- 10.1056/NEJM200102223440803 · DOI
- 10.3171/jns.1979.51.3.0307 · DOI
- 10.3171/jns.1986.65.2.0203 · DOI
- 10.3171/jns.1986.64.1.0081 · DOI
- 10.1136/bmj.320.7245.1308 · DOI
- 10.1089/neu.1997.14.71 · DOI
- 10.1056/NEJM198506203122504 · DOI
- GAAB M.R., 1994, Zentralbl. Neurochir., 55, 135
- 10.1016/S0140-6736(00)02689-1 · DOI
- 10.1097/00006123-198410000-00004 · DOI
- 10.1161/01.STR.26.4.602 · DOI
- 10.3171/jns.1979.51.3.0301 · DOI
- 10.1089/neu.2000.17.451 · DOI
- KONTOS H.A., 1983, Physiologist, 26, 165
- 10.1161/01.RES.57.4.508 · DOI
- LAVIE G., 2000, Am. Soc. Neurosci. Abst., 30, 771
- 10.1517/13543784.10.4.753 · DOI
- 10.1056/NEJM199702203360803 · DOI
- 10.1089/neu.1999.16.431 · DOI
- 10.1097/00006123-200009000-00002 · DOI
- 10.3171/jns.1998.89.4.0519 · DOI
- 10.3171/jns.1999.91.5.0737 · DOI
- 10.3171/jns.1993.78.3.0375 · DOI
- 10.1007/s007010050292 · DOI
- 10.1136/bmj.317.7167.1170 · DOI
- 10.1016/S0891-5849(97)00053-1 · DOI
- 10.1016/S0891-5849(98)00085-9 · DOI
- 10.3171/jns.1981.54.5.0596 · DOI
- 10.1073/pnas.96.15.8721 · DOI
- 10.1016/0006-8993(94)01433-I · DOI
- 10.1016/S0165-5728(96)00181-6 · DOI
- 10.1016/0197-2456(89)90015-9 · DOI · Paper page
- 10.1089/089771501317095232 · DOI
- 10.1089/neu.1998.15.587 · DOI
- 10.1089/neu.1998.15.573 · DOI · Paper page
- 10.1136/jnnp.69.2.204 · DOI
Cited by
Sorted by citations
Items 701–800 of 806
Pharmacologic approaches to cognitive rehabilitation
McAllister, T. W., & Arnsten, A. F. T. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9781316529898.022 · Cited by 2
Brain injury research: lessons for reinventing the future. The 38th Zeiter Lecture.
Zafonte, R. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.02.039 · Cited by 3
Oxidative Damage Mechanisms in Traumatic Brain Injury and Antioxidant Neuroprotective Approaches
Hall, E., Singh, I., & Cebak, J. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-77495-4_3 · Cited by 3
Self-citationBarriers to Drug Delivery for Brain Trauma
Willyerd, F., Empey, P., Kochanek, P. M., & Clark, R. (2014) · doi:10.1007/978-1-4614-8690-9_7 · Cited by 3
“This represents a major challenge for delivery of neuroprotective agents after TBI and may contribute to the failure of current clinical trials in humans that utilize conventional methods of drug delivery [11].”
BackgroundSelf-citationStroke/Traumatic Brain and Spinal Cord Injuries
Hall, E. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00170-x · Cited by 3
Self-citationNeuroglia in traumatic brain injury: Pathophysiology and therapeutic targeting
Suk, K. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.03.002 · Cited by 2
Wang, Y., Sun, X., Liu, M.-M., Dai, Z.-Y., Yang, X., Li, L., & Ding, Y.-P. (2026) · Analytical Methods · doi:10.1039/d5ay01486g · Cited by 2
Muradov, J. H., Reid, H., Parker, E., Phinney, J., Clarke, D. B., Friedman, A., & Maclean, M. A. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2524102 · Cited by 2
“Despite decades of focused research efforts, translation of TBI-directed treatments from preclinical studies to the clinical setting has been complicated by lack of therapeutic efficacy [59] or excessive side-effects/mortality [60,61].”
Tagliabue, S., Rey-Perez, A., Exposito, L., Jimenez, A. F., Angulo, S. V., Maruccia, F., Fischer, J., Kacprzak, M., Poca, M., & Durduran, T. (2024) · medRxiv · doi:10.1117/1.bios.2.1.015001 · Cited by 2
“51,52 Therefore, it is reasonable to assume that if a robust monitor of cerebral autoregulation becomes available, it would be recommendable to utilize it frequently.”
Optimal Partial Pressure of Oxygen Affects Outcomes in Patients With Severe Traumatic Brain Injury
Wiginton, J. G., Brazdzionis, J., Patchana, T., Dorkoski, R., Miulli, D., Sweiss, R. B., & Wacker, M. (2020) · Cureus · doi:10.7759/cureus.9964 · Cited by 2
Direct Brain Cooling in Treating Severe Traumatic Head Injury
Idris, Z., Yee, A., Kandasamy, R., Manaf, A. A., Hassan, M. H. B., & Hassan, W. N. W. (2019) · Traumatic Brain Injury - Neurobiology, Diagnosis and Treatment · doi:10.5772/intechopen.84685 · Cited by 2
“Many clinical trials and researches were conducted to improve our understanding and knowledge, with various treatment protocols being updated from time to time [1, 2].”
BackgroundMagnetic resonance imaging and cell-based neurorestorative therapy after brain injury
Jiang, Q. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.169603 · Cited by 2
“…of brain injury such as stroke and traumatic brain injury is currently either restricted to acute thrombolysis treatment with a short treatment window in stroke (NINDS, 1995), or no effective neuroprotective agents identified from traumatic brain injury clinical trials (Narayan et al., 2002).”
Neuro-proteomics and Neuro-systems Biology in the Quest of TBI Biomarker Discovery
Wang, K. K. W., Zhang, Z.-Q., & Kobeissy, F. (2014) · CRC Press eBooks · doi:10.1201/b17644-7 · Cited by 4
Flavonoids and Neuroinflammation
Vauzour, D. D., & Vafeiadou, K. (2012) · doi:10.1201/b11872-17 · Cited by 2
Hyuk, L., Yoon, J.-H., Jeong, I., Kim, J., Kim, B.-K., Seo, J.-H., Ko, I.-G., Shin, M.-S., Kim, S. E., & Kim, C.-J. (2008) · doi:10.15857/ksep.2008.17.3.363 · Cited by 2
Dexanabinol prevents development of vasospasm in the rat femoral artery model
Durmaz, R., Ozsandik, A., Sahinturk, V., Civi, K., Bayçu, C., Özden, H., & Shimon, A. (2008) · Neurosurgical review · doi:10.1007/s10143-007-0119-z · Cited by 2
“However, dexanabinol is shown to have a long-lasting effect on neuroprotection and its additional injections at 12 or 24 h and 3, 7, or 10 days after the traumatic brain injury presented no further benefit in animals [28, 39].”
BackgroundThe History of Neurosurgery at Temple University
Meagher, R., Buchheit, W., & Narayan, R. (2004) · Neurosurgery · doi:10.1227/01.neu.0000134559.62469.c1 · Cited by 2
“A major NIH-espoused workshop on clinical trials in head injury was successfully conducted that led to publication of an important monograph (21).”
BackgroundSelf-citationCritical Care Management of Traumatic Brain Injury
Robertson, C. S., & Rangel-Castilla, L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00338-5 · Cited by 21
Self-citationStem Cells for Traumatic Brain Injury
Schneider, C. M., Jackson, M. L., Bedi, S. S., & Cox, C. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00023-0 · Cited by 3
Voltage-Gated Calcium Channel Blockers for the Treatment of Traumatic Brain Injury
Gurkoff, G. G., Shahlaie, K., Lyeth, B. G., & Berman, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802686-1.00011-0 · Cited by 2
Himmelseher, S., & Kochs, E. F. (2004) · Springer eBooks · doi:10.1007/978-88-470-2189-1_19 · Cited by 3
Excitotoxicity and Traumatic Brain Injury
Marklund, N., Stover, J. F., & McIntosh, T. K. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_10 · Cited by 2
Self-citationGeng, H., Chen, J., Tu, K., Tuo, H., Wu, Q.-S., Guo, J.-H., Zhu, Q.-W., Zhang, Z., Zhang, Y.-J., Huang, D.-S., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04257-w · Cited by 1
“On the other hand, small-molecule antioxidants possess a weaker ability to scavenge radicals, a shorter duration of action, susceptibility to oxidation, and non-recyclability, thereby hindering their ability to rapidly eliminate excessive ROS [35].”
Mahajan, V., Tandon, V., Gour, S. S. K., Raheja, A., Dhamija, A., Patni, V., Gupta, D. K., Agrawal, D., Kumar, A., & Chandra, P. S. (2026) · Journal of clinical neuroscience · doi:10.1016/j.jocn.2026.111850 · Cited by 1
Harper, M. I., McKinney, K. A., McLennan, C., Adhikari, S. P., Ghodsi, M., Cooper, J. G., Stukas, S. K., Maldonado-Rodriguez, N., Agbay, A. M., Morelli, T., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-098025
“71 84–88 TBI: several consensus conferences over the past decade 89–91 concluded that validated biomarkers for multiple contexts of use (COU) will be instrumental to TBI research and care.”
Rao, K. V. R., Mclean, V., Wilder, D. M., Dahal, S., Kattuparambil, M., Long, J. B., & Sajja, V. S. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115375 · Cited by 1
Tator, C., Guest, J., Neal, C. J., Howley, S., Toups, E. G., Harrop, J. S., Aarabi, B., Shaffrey, C. I., & Fehlings, M. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2022.0404 · Cited by 1
“31 He also participated in other registries.”
Evidence Related to Predictive Scales for Trauma Patients' Outcome: Literature Review
Hassan, A., Ahmed, H., & Kandeel, N. (2022) · Mansoura Nursing Journal · doi:10.21608/mnj.2022.259015 · Cited by 1
“Thereby, the GOS in its original or extended form is recommended as an outcome measure for major trauma and head injury (Ardolino, Sleat, & Willett, 2012; Narayan et al., 2002).”
BackgroundMenacho, S., & Hawryluk, G. (2021) · Journal of clinical neuroscience · doi:10.1016/j.jocn.2021.03.025 · Cited by 1
Perry, E. C., Ahmed, H., & Origitano, T. C. O. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00113-9 · Cited by 1
Li, C., & Narayan, R. (2014) · doi:10.15424/bioelectronmed.2014.00010 · Cited by 1
Self-citationTraumatic Brain Injury and Intracranial Hypertension
McCullagh, I., & Andrews, P. (2012) · doi:10.1002/9781118297162.ch3 · Cited by 1
Lessons from traumatic head injury for assessing functional status after brain tumour
Wilson, L. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0812-9 · Cited by 1
The Multifocal Cerebral Infarctions in Patient after Epidural Hematoma Evacuation
Son, J.-H., Shin, I., Chung, Y.-G., & Park, K.-J. (2010) · doi:10.13004/jknts.2010.6.1.66 · Cited by 1
Corticosteroids and head injury.
Agrawal, A., Cincu, R., & Timothy, J. (2008) · Clinical neurology and neurosurgery (Dutch-Flemish ed. Print) · doi:10.1016/j.clineuro.2007.12.011 · Cited by 1
Treatment of Severe Pediatric Head Injury: Evidence-Based Practice
Smith, J. D. (2005) · doi:10.1201/b14222-16 · Cited by 1
Do we and should we monitor intracranial pressure in infants with closed head injury?
Duhaime, A. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000170618.91297.08 · Cited by 1
Head Injury: The Relentless Enemy
Tandon, P. (2004) · Indian Journal of Neurotrauma · doi:10.1016/s0973-0508(04)80001-7 · Cited by 1
What works in severe head injury?
Ferdinande, P. (2001) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200104000-00005 · Cited by 1
Mondello, S., & Hasan, A. (2020) · Frontiers Research Topics · doi:10.3389/978-2-88963-449-1 · Cited by 1
Naeser, M. A., Martin, P. I., Ho, M. D., Krengel, M., Bogdanova, Y., Knight, J., Fedoruk, A., Hamblin, M. R., & Koo, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815305-5.00025-7 · Cited by 1
Mechanisms and Clinical Applications of Stem Cell Therapy
Tora, M. S., Poth, K. M., Hardcastle, N., Sandor, K. P., Anthony, C., Di, L., & Boulis, N. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00008-6 · Cited by 1
Clinical Trials for Traumatic Brain Injury: Designs and Challenges
Lü, J., & Gormley, M. A. (2018) · Neuromethods · doi:10.1007/978-1-4939-8564-7_22
Cerebral Resuscitation and Traumatic Brain Injury
Fink, E., Kochanek, P., & Clark, R. (2012) · doi:10.1007/978-0-85729-923-9_31 · Cited by 1
Self-citationShah, S. K., Jimenez, F., & Walker, P. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-965-9_4 · Cited by 1
10 – Modulation of Immune Response by Head Injury
Morganti-Kossmann, C., Semple, B., Ziebell, J. M., Yan, E., Bye, N., & Kossmann, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384691-4.00010-9 · Cited by 1
Chapter 17 – Traumatic Brain Injury
Callahan, B. P., & Rabb, C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05711-0.00017-3 · Cited by 1
Acute Seizures and Status Epilepticus
Herman, S. T. (2006) · Elsevier eBooks · doi:10.1016/b978-012648082-5/50008-3 · Cited by 2
Functional tolerance to mechanical deformation developed from organotypic hippocampal slice cultures
Kang, W. H., & Morrison, B. (2014) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-014-0622-4 · Cited by 25
Predicting changes in cortical electrophysiological function after in vitro traumatic brain injury
Kang, W. H., & Morrison, B. (2015) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-015-0652-6
Tandon, P. (2015) · National academy science letters · doi:10.1007/s40009-015-0419-8
How Many Brain Injury Guidelines Do We Need?
Hawryluk, G. W. J. (2026) · Neurosurgery · doi:10.1227/neu.0000000000004002
Sharratt, C. A., Hall, J. L., Crack, P. J., & Tan, H. X. (2026) · Pharmaceuticals · doi:10.3390/ph19101659
“…the clinical translation of therapies for TBI, including more comprehensive characterisation of secondary injury mechanisms, improved understanding of drug pharmacokinetics, optimisation of dosing regimens and therapeutic windows, and evaluation across multiple injury models and age groups [19–21].”
Translational Inefficiencies in Traumatic Brain Injury Research: Evidence From 94 399 Publications.
de Souza, D. N., Frome, S., Grin, E. A., Grossman, S. N., Huang, P. P., & Kurland, D. (2026) · Neurosurgery · doi:10.1227/neu.0000000000004208
Lv, Y., Yang, M.-S., Niu, F., Zhuang, Y., Liu, W.-M., Gao, G.-Y., Liu, B.-Y., & Tian, R. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01038
“Although preclinical studies have demonstrated the neuro-protective potential of NMDAR antagonists, their clinical trials have not translated into success [14 – 16].”
Manuel, P. B. V., Victoria, P. A. G., & Ahissou, Z. M. C. (2026) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2026.01.002
Fayaz, M., Jauher, M., Khursheed, A., Singh, S., Wani, A., Arif, S., & Malik, N. (2026) · Indian Journal of Neurosurgery · doi:10.1055/s-0046-1819586
“4 However,weexcludednonquanti fi edpathologies(e.g., contusions without volume measurements), potentially undermining the role of multifocal injuries.”
Gunshot head injuries in Dhaka amid the violent crackdown in July 2024
Kuddus, M., Tabassum, F., Rahman, M. M., Alam, S., & Sharif, M. (2026) · Bangabandhu Sheikh Mujib Medical University Journal · doi:10.3329/bsmmuj.v19i1.85581
“Among the 119 operated patients, the use of local anaesthesia in nearly half reflects a pragmatic approach adapted to patient condition and resource availability, consistent with best practices in civilian neurosurgical trauma [ 18, 19].”
Gjesdal, B. J., Rao, S., Parchuri, E., Rohde, Z., Henchir, J. J., Li, Y., Chang, Y.-F., Carlson, S. W., & Dixon, C. E. (2026) · Neurotrauma Reports · doi:10.1177/2689288x261435303
Wang, X., Pang, H., Chopp, M., Zhang, Y., Chen, L., Zhang, Z. G., Zhang, L., & Xiong, Y. (2026) · Neurotrauma Reports · doi:10.1177/2689288x261480487
Sharma, S., Shukla, D., Chaube, S., & Akram, N. (2025) · Asian Journal of Medical Sciences · doi:10.71152/ajms.v16i9.4693
Schantz, S. L., LePage, T. H., Dubrof, S., Sneed, S. E., Cheek, S. R., Park, H., Barany, D. A., Kinder, H. A., Duberstein, K., DeWahl, D. A., et al. (2025) · Journal of Neurotrauma · doi:10.1177/08977151251363584
“9 – 11 To help address this need, we evaluated the effect of the novel ALA-based therapeutic, alpha-N -[(R)-1, 2-dithiolane-3-pentanoyl] L -glutamyl- L -alanine (CMX-2043), on cellular, tissue, and functional recovery in a well-characterized porcine TBI model.”
Zhang, Y.-F., Wang, Y., & Wang, Q.-P. (2024) · Iranian Journal of Radiology · doi:10.5812/iranjradiol-153417
Raghuwanshi, B., Florez-Perdomo, W., Mishra, R., Moscote-Salazar, L. R., Cincu, R., & Agrawal, A. (2024) · Indian Journal of Neurotrauma · doi:10.1055/s-0044-1779430
“36 – 39 It is anticipated that the results of the ongoing multicenter study Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase 3 (BOOST-3) will further show the comparative”
BackgroundChen, L., Xiong, Y., Chopp, M., Pang, H.-Y., Emanuele, M., Zhang, Z.-G., Mahmood, A., & Zhang, Y.-L. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105659
“Indeed, pharmacological agents targeting mechanisms underlying the TBI-induced secondary injury show the therapeutic effects (Diaz-Arrastia et al., 2014; Dixon, 2017; Narayan et al., 2002).”
Sodium Imbalance as a Marker of Prognosis of Outcome in Patients with Traumatic Brain Injury
Khambhu, B., Jha, R., & Bista, P. (2020) · Nepal Journal of Neuroscience · doi:10.3126/njn.v17i3.33121
Choudhary, M., Khan, K., Gora, N., Sharma, A., & Sinha, V. (2020) · Indian Journal of Neurosurgery · doi:10.1055/s-0040-1708066
Tümör Nekroz Faktörü Alfa Blokeri Adalimumabın Deneysel Beyin Hasarında Etkileri
Günal, M., Çankaya, Ş., Tonuk, S. B., Ozdemir, E., & Şakul, A. A. S. (2019) · Acta Medica Alanya · doi:10.30565/medalanya.632455
Management of Head Trauma in the Neurocritical Care Unit
Roux, P. L. (2019) · Cambridge University Press eBooks · doi:10.1017/9781107587908.017
Stem Cell Therapy in Pediatric Neurological Disorders
Torabian, F., Nejad, A. A., Rezayat, A. A., Toosi, M. B., Rahimi, H., & Nakhaie, A. (2015) · doi:10.22038/ijp.2015.4426
“Pharmacological-based therapies have been lost to obtain positive effect(68, 70).”
Protein Biomarkers for Mild Traumatic Brain Injury
Papa, L., Ameli, N., Waplinger, A., Zhang, Z.-Q., & Wang, K. K. W. (2014) · doi:10.1201/b17644-10
Macas, A., Bilskienė, D., Vilkė, A., & Gedminas, M. (2014) · Sveikatos mokslai · doi:10.5200/sm-hs.2014.025
Traumatic Brain Injury - Acute Care
Hays, A. N., & Varma, A. (2012) · doi:10.5772/29491
Morris, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6842-5_18
Not if but when; no longer why but how
Piper, I. (2007) · Critical Care · doi:10.1186/cc5688
Status Quo of Severe Head Injury Management
Kim, H.-J. (2005) · doi:10.13004/jknts.2005.1.1.1
Variability of SF-36 scores within gose categories
Outtrim, J., Chatfield, D., Conway-Smith, C., Shephard, E., Moore, L., Hutchinson, P., Pickard, J., & Menon, D. (2005) · doi:10.1038/sj.jcbfm.9591524.0560
Regional is Chaemia following Acute Head Injury
Coles, J. (2005) · Journal of the Intensive Care Society · doi:10.1177/175114370500600116
Defining emerging evidence for osmotherapy in traumatic brain injury.
Myburgh, J. (2004) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)02168-3
Intracranial pressure monitoring in pediatric ICU
Kuroda, Y. (2004) · doi:10.3918/jsicm.11.182
Therapeutic options for head injury in intensive care.
Myburgh, J. (2002) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01184-5
Bispectral index and intensive care--an alluring concept.
Ludbrook, G. (2001) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01270-x
Cerebral Resuscitation and Traumatic and Hypoxic-Ischemic Brain Injury
Fink, E., Au, A. K., Simon, D. W., Kochanek, P., & Clark, R. (2021) · doi:10.1007/978-3-030-53363-2_25
Self-citationNeuroprotective Strategies Following Experimental Traumatic Brain Injury
Kulbe, J. R. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.228
“such as GCS score, lack of sensitivity in outcome measures or use of inappropriate outcome measures, lack of appropriate subgroup analyses, inadequate pre-clinical experimental design, and lack of understanding of secondary injury mechanisms [9, 211, 213, 214].”
BackgroundYdyrysov, I., Yrysov, B., Kalyev, K., & Yrysov, K. (2019) · Likarska sprava · doi:10.31640/jvd.5-6.2019(14
Schurman, L. D. (2018) · doi:10.25772/8t1v-rt57
“Yet, thus far, all late phase clinical trials have failed to yield an effective anti-inflammatory neuroprotective treatment (Chakraborty et al, 2016; Narayan et al, 2002).”
BackgroundImproving Approaches to Evaluate Efficacy and Safety of Drugs for Traumatic Brain Injury
Maas, A. I. R., & Menon, D. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804064-5.00006-0
Self-citationAcute Seizures and Status Epilepticus
Herman, S. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804064-5.00010-2 · Cited by 1
Molecular Biology of Brain Injury: 2012
Whalen, M. J., Yager, P. H., Lo, E. H., Lok, J. M., Dapul, H. R., Murphy, S. A., & Noviski, N. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6356-5_33
Stahel, P., & Flierl, M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8551-3_13
Chapter 20 – Closed Head Injury
Houseman, C. M., Belverud, S., & Narayan, R. (2012) · doi:10.1016/b978-1-4377-0701-4.00020-8
Self-citationCurrent Concepts of Hypothermia in Traumatic Brain Injury
Dietrich, W., & Bramlett, H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00333-6
Self-citationTraumatic Brain Injury: Relationship of Clinical Injury to Progenitor Cell Therapeutics
Cox, C., Baumgartner, J., Ewing-Cobbs, L., & Day, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-965-9_6
Metadata
- Authors
- Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., Coplin, W. M., Dietrich, W. D., Ghajar, J., Grady, S. M., Grossman, R. G., Hall, E. D., Heetderks, W., Hovda, D. A., Jallo, J., Katz, R. L., Knoller, N., Kochanek, P. M., Maas, A. I., Majde, J., Marion, D. W., Marmarou, A., Marshall, L. F., McIntosh, T. K., Miller, E., Mohberg, N., Muizelaar, J. P., Pitts, L. H., Quinn, P., Riesenfeld, G., Robertson, C. S., Strauss, K. I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M. D., Weinrich, M., Whyte, J., Wilberger, J., Young, A. B., & Yurkewicz, L.
- Affiliations
- Temple University Hospital (US)
- National Institute of Neurological Disorders and Stroke (US)
- National Institutes of Health (US)
- Ludwig-Maximilians-Universität München (DE)
- Lawrence Berkeley National Laboratory (US)
- Yale University (US)
- Virginia Commonwealth University (US)
- The University of Texas Health Science Center at Houston (US)
- Baylor College of Medicine (US)
- Wayne State University (US)
- University of Miami (US)
- Brain Trauma Foundation (US)
- Hospital of the University of Pennsylvania (US)
- Pfizer (United States) (US)
- University of California, Los Angeles (US)
- Temple University (US)
- United States Food and Drug Administration (US)
- Sheba Medical Center (IL)
- University of Pittsburgh (US)
- Academisch Ziekenhuis Rotterdam (NL)
- Office of Naval Research (US)
- University of California San Diego (US)
- University of California Davis Medical Center (US)
- University of California, San Francisco (US)
- Southern General Hospital (GB)
- University of Washington (US)
- Allegheny General Hospital (US)
- Albert B. Chandler Hospital (US)
- ORCID
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2002-05
- Volume
- 19
- Issue
- 5
- Pages
- 503-557
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- PMC
- PMC1462953
- OpenAlex
- W2045663952
- Cited by
- 913
- References
- 0
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 20 · 2023: 14 · 2022: 15 · 2021: 20 · 2020: 35 · 2019: 43 · 2018: 43 · 2017: 40 · 2016: 42 · 2015: 55 · 2014: 49 · 2013: 56 · 2012: 61
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neurotrauma (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Deep Blue (University of Michigan) (submittedVersion, public-domain)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- National Institutes of Health (7r01ns038654-04)
- National Institute of Neurological Disorders and Stroke (R01-NS038654)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Physical Sciences › Engineering › Biomedical Engineering › Automotive and Human Injury Biomechanics
- Keywords
- traumatic brain injury, clinical trial design, closed head injury, penetrating head injury, translational research, treatment failure, long-term disability
- MeSH terms
- Brain Injuries, Clinical Trials as Topic, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review